ltrafiltration (UF) Effectiveness on intradialytic hypertension (IDH)

Not Applicable

• Conditions: Kidney Disease

• Registration Number: PACTR202001714181321
• Lead Sponsor: ephrology department

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-12-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

All chronic hemodialysed patients (for more than 3 months) in Aristide Le Dantec hemodialysis units, undergoing IDH, aged at least 18 years and consenting to the study were included.

Exclusion Criteria

Missing 3 sessions out of the last 6 before randomization; a clinical volume overload; clinical dehydration; intolerance to UF; severe cardiovascular comorbidities (stroke, ischemic heart disease, severe lower limbs obliterating arteriopathy (LLOA) or left ventricular ejection fraction (LVEF) less than 50%); deciding to not participate in the study; chronic hypotension.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progressive UF was associated with a significant reduction in the prevalence of IDH in our patients at week 4.<br>

Secondary Outcome Measures

Name	Time	Method
ultrafiltration was not always well tolerated.